United States: US Expands List Of Medical Items Authorized For Export Or Re-Export Under Iran General License

On November 2, 2015, the US Department of the Treasury's Office of Foreign Assets Control ("OFAC") updated and expanded the list of "medical supplies" that can qualify for export or re-export to Iran under the existing general license for medicine and medical supplies. While this modification does not, by its terms, relax the general commercial embargo on Iran, or the wide range of extraterritorial or "secondary" sanctions, it does provide additional opportunities for lawful trade with Iran—subject to certain limitations on the types and terms of financing, delivery and performance obligations, which parties can be involved and alignment with export control considerations.

US sanctions and the general license for medical supplies

The Iranian Transactions and Sanctions Regulations ("ITSR," 31 CFR Part 560) prohibit US Persons1 and entities they own or control, including foreign subsidiaries, from engaging in or facilitating nearly all commercial transactions involving Iran.

However, the ITSR contains a general license, which authorizes the exportation or re-exportation of certain "medical supplies" to Iran. This general license also authorizes "related transactions," such as "making of shipping and cargo inspection arrangements, the obtaining of insurance, the arrangement of financing and payment, shipping of the goods, receipt of payment, and the entry into contracts (including executory contracts)." 31 CFR 560.530(a)(3)(i). So long as a given export or re-export is in line with the terms of the general license, no further authorization from OFAC is required to proceed. (A "specific license" from OFAC would be required for any transaction not within the parameters of the general license.)

OFAC's expansion of the medical supplies list

The general license in Part 560.530(a)(3)(i) covers the "medical supplies" expressly listed by OFAC on its website. The November 2, 2015, change removes the word "basic" from the title of the list of medical supplies covered by the license2 and alphabetizes and expands the items listed. You may find the revised list here. Notably, the revised list adds two new categories of products: (1) Inherited Preventative Care, which covers genetic testing products, and (2) Otology and Neurotology, which covers hearing aids, accessories and components. The revised list also adds several items to the categories of General Medical Equipment and Supplies, Cardiology, Dental Equipment and Supplies, Gynecology & Urology, Laboratory, Neurology, Obstetrics and Maternity Care, Ophthalmology and Optometry, Physical and Occupational Therapy, Radiology, and Surgery. The Anaesthesiology, Apparel, Nephrology, and Sterilization categories did not change.

The general license remains limited

As a result of the November 2, 2015 update, a wider range of items can qualify for the general license. However, the general license contains several important conditions with which subject transactions must comply:

  • Financing and payment terms. The general license applies only to transactions involving payment of cash in advance; certain sales on open account; financing by third-country (i.e., non-US, non-Iranian) financial institutions that are not owned or controlled by a US Person (though a US financial institution can confirm or advise on such financing); or certain types of letters of credit issued by an Iranian financial institution blocked solely for being Iranian (and not because of its association with terrorism, for example) so long as the letter of credit is initially advised, confirmed, or otherwise dealt in by a third-country financial institution. See § 560.532. Transactions pursuant to the general license cannot involve debiting a blocked or frozen account, or debits or credits to Iranian accounts on the books of a US depository institution.
  • Contract duration and performance. All exports or re-exports under the general license must be shipped within the 12-month period beginning on the date of the signing of the contract for export or re-export.
  • Prohibited counterparties. The general license does not authorize exports or re-exports to military and law enforcement purchasers or importers. It also does not authorize exports or re-exports to certain persons on OFAC's Specially Designated Nationals and Blocked Persons List who have been targeted for sanctions because of, among other things, their connections to terrorism, or the proliferation of weapons of mass destruction,
  • Export control considerations. The general license applies only to medical supplies that are designated as "EAR99" for purposes of US export controls or which would be so designated if they were located in the United States.

Conclusion

The expanded list of "medical supplies" eligible for the general license may create additional opportunities for lawful trade with Iran. However, significant restrictions on trade with Iran remain in place, including under the general license itself.

The commercial landscape for doing business with Iran remains fluid. The recent agreement on Iran's nuclear program is likely to significantly impact this landscape. Accordingly, active monitoring of this issue is critical to identifying opportunities as well as understanding the evolving restrictions.

Below is the list of newly added items to the Medical Supplies list under 31 C.F.R. 560.530(a)(3)(ii) on November 2, 2015:

General Medical Equipment and Supplies:

  • Bottles (prescription)
  • Capnographs
  • Contraceptives (inter-uterine devices (IUDs), hormonal therapy methods, barrier methods)
  • Continuous positive airway pressure (CPAP) systems and all components
  • Humidifiers
  • Medical flowmeters: oxygen & air
  • Medical pumps
  • Oxygen apparatus, all
  • Pulse oximeters
  • Refrigerator: compartmental for morgues
  • Spirometers
  • Aspirators – all sizes and types; including kits
  • Tents: pediatric, aerosol, and mist
  • Ventilator: adult and tubing and accessories

Cardiology:

  • Ablation devices and accessories: radio frequency
  • Balloons extractor, retrieval
  • Cardiac monitors: implantable or external
  • Cardiac pacemakers
  • Cardiac programmers
  • Cardiopulmonary oxygenation systems, devices, and monitors
  • Coagulation machines
  • Filters: arterial
  • Grafts: peripheral bypass
  • Heart positioners: surgical revascularization
  • Heart valves: surgical transcatheter (non-surgical)
  • Inflation devices: interventional

Dental equipment and supplies

  • Bone graft matrices
  • Dentures, crowns, molds, orthodontics, all

Gynecology & Urology

  • Extracorporeal lithotripters

Laboratory

  • Autoclaves (20 liters or smaller only) for medical instrument sterilization and accessories
  • Flow cytometry accessories, reagents, and components

Neurology

  • Neurostimulators, implantable

Obstetrics and Maternity Care

  • Assisted reproductive technology and related equipment
  • Incubators/Isolettes
  • Infant radiant warmer and parts and accessories
  • Neonatal equipment (phototherapy, nasal CPAP, etc. and all components)
  • Ventilator: infant/pediatric and tubing and accessories

Ophthalmology and Optometry

  • Phoropters
  • Tonomets
  • Vision/Optometry related machines and supplies

Physical and Occupational Therapy

  • Bath cubes, therapy
  • Boots, mitts, and liners for therapeutic pain relief
  • Manipulation boards
  • Orthopedic shoes, boots, etc.

Radiology

  • Computer tomography scanners (CT, MDCT)
  • Contrasting agents, both injectable or non-injectable
  • Magnetic resonance imaging (MRI) machines
  • Medical/Dental film
  • Nuclear medicine imaging machines
  • Positron Emission Tomography (PET)
  • PET cyclotron machines
  • PET radiopharmaceutical tracer machines, including cassettes
  • Scintillation Camera/Anger cameras for medical imaging
  • Single Photon Emission Computed Tomography (SPECT) machines
  • X-ray machines, including mammography machines
  • Parts and accessories for medical imaging devices above that do not contain nuclear or chemical components

Surgery

  • Cervical fusion kits
  • Cosmetic or reconstructive implants (jaw implants, breast implants, skin grafts)
  • Orthopedic plates/screws, fixators, implants, cement
  • Surgical imaging machines; including image-guiding surgery products, ear, nose and throat
  • Surgical shunts
  • Tissue stabilizers, surgical revascularizations

Footnotes

1 The ITSR defines a US Person to mean "any United States citizen, permanent resident alien, entity organized under the laws of the United States (including foreign branches), or any person in the United States." 31 CFR 560.314. Under 31 CFR 560.215(b), an entity is "owned or controlled" by a US Person if the US Person (i) holds 50 percent or more interest in the entity, (ii) holds a majority of seats on the entity's board of directors, or (iii) "otherwise controls the actions, policies, or personnel decisions of the entity."

2 OFAC had removed the term "basic" from the definition of medical supplies in the general license itself in April 2014, but the "List of Basic Medical Supplies" on OFAC's website had not been updated since 2013.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Events from this Firm
26 Sep 2018, Conference, New York, United States

Dentons is delighted to support a global IT services and consulting firm Miratech as an event host partner at their annual conference called M-Force18 New York on September 27th. The event will be held at Dentons New York office in the heart of Midtown Manhattan, opposite Rockefeller Center.

2 Oct 2018, Seminar, Dallas, United States

We are pleased to offer a program of five sessions designed specifically for in-house counsel. Topics will include:

  • In-house corporate ethical issues
  • What recent Supreme Court decisions mean for business
  • Keeping lawyers out of your benefit plans
  • Litigation tactics for in-house counsel
  • Employment issues in the age of #MeToo
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions